Paper22096243
EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.
Kimura H and 12 others. Blood, 2012. Cited by 373 papers, by iCite.
Cite this record
ConductScience Library. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Papers, record 22096243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22096243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epstein-Barr Virus Infections | Major topic |
| Herpesvirus 4, Human | Major topic |
| Killer Cells, Natural | Major topic |
| Lymphoproliferative Disorders | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Child, Preschool | |
| DNA, Viral | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Immunocompromised Host | |
| Infant | |
| Male | |
| Middle Aged | |
| Polymerase Chain Reaction | |
| Prognosis | |
| Prospective Studies | |
| Survival Rate | |
| Young Adult |
Source PubMed
Cited by212
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 373 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964629 | Chronic Active Epstein-Barr Virus (EBV) Disease with Haemophagocytic Lymphohistiocytosis and Abnormal T/NK Cells. | EJHaem | 2026 | https://conductscience.org/library/papers/42964629 | PubMed |
| 42898306 | Epstein-Barr virus-associated T/NK-cell lymphoproliferative diseases with heterozygous IL10RA variants: two cases with pedigree analysis and a literature review. | Glob Med Genet | 2026 | https://conductscience.org/library/papers/42898306 | PubMed |
| 42859941 | Time-Dependent Prognostic Value of the sCD25-to-Ferritin Ratio in Chronic Active Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis. | Infect Dis Ther | 2026 | https://conductscience.org/library/papers/42859941 | PubMed |
| 42656448 | A case series study of fever-diarrhea-hematochezia triad as the first presentation in plasma EBV DNA-positive diseases. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42656448 | PubMed |
| 42614304 | Immune checkpoint inhibitors in infectious diseases: therapeutic reinvigoration, immunopathology, and precision targeting. | Front Immunol | 2026 | https://conductscience.org/library/papers/42614304 | PubMed |
| 42524018 | The role of Epstein-Barr virus in NK/T cell lymphoproliferative disorders: molecular mechanisms and potential therapeutic strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42524018 | PubMed |
| 42449853 | Sequential [11C]Acetate and [18F]FDG PET/CT Assessment of Systemic Chronic Active Epstein-Barr Virus Disease: An Exploratory Retrospective Study. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42449853 | PubMed |
| 42327794 | Case Report: A diagnostic chameleon of EBV-associated immune dysregulation: HLH unmasking multiple myeloma with subsequent emergence of aggressive B-cell lymphoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42327794 | PubMed |
| 42261307 | ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT. | J Blood Med | 2026 | https://conductscience.org/library/papers/42261307 | PubMed |
| 42207336 | Clinicopathological characteristics of a rare group of chronic active Epstein-Barr virus disease involving the gastrointestinal tract. | J Hematop | 2026 | https://conductscience.org/library/papers/42207336 | PubMed |
| 42108635 | Clinical features and prognostic factors of adult systemic chronic active EBV disease: A retrospective analysis in Japan. | Br J Haematol | 2026 | https://conductscience.org/library/papers/42108635 | PubMed |
| 42104364 | EBV DNA load and cytokines guide risk-stratified treatment in pediatric EBV-associated hemophagocytic lymphohistiocytosis. | Virol J | 2026 | https://conductscience.org/library/papers/42104364 | PubMed |
| 42099645 | Case Report: A case of severe mosquito bite allergy in an elderly patient. | Front Immunol | 2026 | https://conductscience.org/library/papers/42099645 | PubMed |
| 42005194 | Immune Hyperactivation in Epstein-Barr Virus (EBV)-Driven T-cell Lymphoproliferation: A Pediatric Case of Hemophagocytic Syndrome. | Cureus | 2026 | https://conductscience.org/library/papers/42005194 | PubMed |
| 41929472 | Cardiovascular complications in chronic active Epstein-Barr virus infection: a narrative review. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/41929472 | PubMed |
| 41729084 | A machine learning-based triage system for systemic EBV-positive T/NK cell lymphoproliferative diseases of childhood. | JCI Insight | 2026 | https://conductscience.org/library/papers/41729084 | PubMed |
| 41708804 | Avoidance of related donors in CAEBV with germline immune variants: long-termoutcome of matched unrelated donor HSCT - a case report. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41708804 | PubMed |
| 41703988 | Clinical and Pathological Characteristics of Skin Cancer Patients at Southern Medical University, Guangzhou, China. | Acta Derm Venereol | 2026 | https://conductscience.org/library/papers/41703988 | PubMed |
| 41510998 | Epstein-Barr Virus-Associated T/NK-Cell Neoplasms. | J Med Virol | 2026 | https://conductscience.org/library/papers/41510998 | PubMed |
| 41394873 | Flow cytometric analysis of the immune cell subsets in adult hemophagocytic lymphohistiocytosis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41394873 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22096243
GET https://conductscience.org/api/papers/v1/22096243/cited_by?page=2